Prostrakan Share Discussion Threads

[grimraider] 03/3/2009 17:51

What happened?

[grimraider] 27/2/2009 17:26

US Healthcare looks likely to take quite a hit if this goes through

US President Barack Obama proposed spending $634 billion to expand healthcare in the country, financing the budget with measures that include less government money for some drugmakers and health insurers. The budget proposal also aims to raise the rebates on drugs used by Medicaid patients to 22 percent of the manufacturer's price, up from 15 percent.

Difficult to assess impact on current and future Prostrakan US launches but must be negative

[shuisky] 09/2/2009 21:43

SdG - Do you post on motley fool? And would you be interested in preparing/contributing a few questions to Prostrakan?

[symphonie des grauen] 09/2/2009 10:11

it's a shame the company can't disclose financial details of these outsourcing agreements so we can value the company a little more accurately.

PSK will explode in the next 12 months IMO.

[symphonie des grauen] 08/2/2009 21:41

been watching myself but gonna wait until the company starts to produce solid revenue and cash through recurring sales. If they break the US then PSK will do very well.

At the moment there is zero interest in the company from the market so it seems the market also is awaiting results from their expansion into the US.

Any upward life in the price to and above 100p should signal positive developments.

watching price,volume and newsflow but all at present are flat-lining so wait until all three pick up and then take a position

[shuisky] 08/2/2009 21:31

This is an interesting company. I was wondering if anyone could help me accelerate my learning on this company. Specifically, does anyone have any insight or perspective on the shareholders...


From

'Institutional investors

Leading Institutional investors in ProStrakan:

Warburg Pincus International Partners LP 17.93%
Aventis Pharma SA 12.70%
Warburg Pincus Private Equity VIII LP 10.71%
LMS Capital plc 8.79%
Warburg Pincus Equity Partners LP 6.37%
BNY/OCS/Nominees Limited (3i plc) 6.27%
Morstan Nominees Ltd 4.91%'


So, the major shareholders all appear to be either early stage shareholders or nominee holdings. Where are the institutional shareholders? Are their any major institutions supporting PSK?

[password] 27/11/2008 12:39

Ah, is current news re Bayer why he was buying?

[password] 20/11/2008 20:23

Big boss buying shares as Gov announce new Price regulation with reduction in price to NHS - President B O'B intent on reducing US Healthcare costs, interesting times ahead, at least US launch benefit from Strong dollar

Where do we go from here?

[paul p] 30/10/2008 23:28

Considering its not yet profit making it is holding up remarkably well. Just wish I had bought more on the dip. It would be good to get some news on the marketing and funding side, it can't be far away.

[armistead34] 30/10/2008 12:21

Does there need to be a reason?
1/ it's not profit making - yet (is it?)
2/ it's under £1

I was surprised to see it hold up so well. Seems to be a great story, but I'm not in it at the current time/climate.

[paul p] 27/10/2008 18:04

I still havn't worked out why the big drop in the price. Am I missing something obvious or what?

[borderriever] 27/10/2008 15:58

Another share thats just joined the bloody good buy at these prices club.

[paul p] 20/10/2008 18:56

The share price is doing well in the current climate but I can't see it really taking off until the new products hit the market in the next few months. The board have made all the right moves to date and I can only see that carrying on. Quality sells and these drugs sell themselves because of the market they are aimed at.Personally I think its just a case of sitting tight and accumulating on any weakness in the price.

[armistead34] 20/10/2008 15:59

What a stalwart! Anyone else looking at this share?

[armistead34] 08/10/2008 22:28

edit: just reread this: previous post, wrong board!

PSK holding up well, in the 90s! Hmm. Either being overlooked by the market cos too small, or being considered very good value..

[paul p] 06/10/2008 21:07

I can't see a problem with the funding and from what I have read and seen from the company, everything was simply waiting for the FDA approval. Even in the current climate the share price is holding well around the £1 resistance level. In a very uncertain climate I am more than willing to have a punt on this one.

[password] 18/9/2008 08:12

Is the current turmoil likely to impinge on the loan facility and or Novaquests funding and thus the financing of the US launch?

Comment anyone

[armistead34] 15/9/2008 16:26

From what little i understand about this share, (I have no position currently) this is top news. However, since it's not yet making a profit, difficult to know how to value it.

Perversely, I'd prefer to be a buyer when I see it form resistance over the £1.00 level. Easy to be sucked down into penny sharedom.

Bach, sounds like you've got your priorities right. They say bulls markets climb a wall of worry, and Schwartz is calling the beginning of one, but I can totally understand your thinking. Good luck to you.

[bach is dead] 15/9/2008 13:30

ive liquidated everything full stop. I can't take the risk of being in anything in these mkts. got too many people to look after and they come first. This afternoon could prove decisive for the direction of all markets globally.

the bottom, when?

[m1dge] 15/9/2008 13:05

BACH IS DEAD,

Presumably your the same BACH who is in to POLO? Your not watching CORAC as well?

Agree with the sentiment and in fact bought more this morning in anticipation of a sustained rise only to be dissapointed. On the basis of volumes this is a little known stock.

[bach is dead] 15/9/2008 12:56

it's a pity PSK chose to release this news to the mkt today. I suspect the stock would have performed very well today if it were not for the calamity around us